Literature DB >> 22891185

Health care utilization by preterm infants with respiratory complications in Quebec.

Jennifer Sophie Landry1, Dan Croitoru, Yulan Jin, Kevin Schwartzman, Andrea Benedetti, Dick Menzies.   

Abstract

INTRODUCTION: Despite notable advances in prenatal and neonatal care, respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) remain important complications of preterm births, and their long-term sequelae are poorly understood.
OBJECTIVE: To describe health care utilization and costs over a 16- to 25-year follow-up period in a cohort of preterm infants with respiratory complications.
METHODS: Using provincial health administrative databases from Quebec, a cohort of individuals who were born prematurely with complications of RDS and⁄or BPD between 1983 and 1992 were identified. From these databases, which cover all Quebec residents, health services use, medication prescriptions, associated diagnoses and costs were tabulated.
RESULTS: A total of 3442 subjects with respiratory complications following preterm birth were identified, of whom 773 had been diagnosed with BPD and 2669 had RDS without BPD. Asthma was diagnosed twice as frequently (1.7 to 2.4 times) in the BPD group compared with the RDS group, with more frequent hospital readmission, and outpatient and emergency room visits. Although respiratory causes remained the main reason for consultation in both groups, 3.7% and 3.4% of the outpatient visits were for mental or psychological ailments, such as depression, attention deficit hyperactivity disorder or dysthymia for the BPD and RDS groups, respectively.
CONCLUSION: BPD patients experienced more hospital admissions, outpatient and emergency rooms visits, and were more likely to suffer from respiratory illnesses and to use respiratory drugs than RDS patients. Neurological and psychiatric complications occurred at a high frequency in both RDS and BPD subjects, and were associated with significant use of antipsychotic and antidepressant medications.

Entities:  

Mesh:

Year:  2012        PMID: 22891185      PMCID: PMC3411390          DOI: 10.1155/2012/606507

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  14 in total

1.  The economic consequences of preterm birth during the first 10 years of life.

Authors:  Stavros Petrou
Journal:  BJOG       Date:  2005-03       Impact factor: 6.531

2.  Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children.

Authors:  Cornelieke Sandrine Hanan Aarnoudse-Moens; Nynke Weisglas-Kuperus; Johannes Bernard van Goudoever; Jaap Oosterlaan
Journal:  Pediatrics       Date:  2009-07-27       Impact factor: 7.124

3.  Functioning at school age of moderately preterm children born at 32 to 36 weeks' gestational age.

Authors:  Anneloes L van Baar; John Vermaas; Edwin Knots; Martin J K de Kleine; Paul Soons
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

4.  Long-term impact of bronchopulmonary dysplasia on pulmonary function.

Authors:  Jennifer S Landry; Tiffany Chan; Larry Lands; Dick Menzies
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

5.  Review series: What goes around, comes around: childhood influences on later lung health? Long-term follow-up of infants with lung disease of prematurity.

Authors:  Indra Narang
Journal:  Chron Respir Dis       Date:  2010       Impact factor: 2.444

6.  Bronchopulmonary dysplasia: incidence, risk factors and resource utilization in a population of South American very low birth weight infants.

Authors:  Jose L Tapia; Daniel Agost; Angelica Alegria; Jane Standen; Marisol Escobar; Carlos Grandi; Gabriel Musante; Jaime Zegarra; Alberto Estay; Rodrigo Ramírez
Journal:  J Pediatr (Rio J)       Date:  2006 Jan-Feb       Impact factor: 2.197

7.  Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants.

Authors:  Suh-Fang Jeng; Chyong-Hsin Hsu; Po-Nien Tsao; Hung-Chieh Chou; Wang-Tso Lee; Hsin-An Kao; Han-Yang Hung; Jui-Hsing Chang; Nan-Chang Chiu; Wu-Shiun Hsieh
Journal:  Dev Med Child Neurol       Date:  2008-01       Impact factor: 5.449

8.  Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study.

Authors:  Malika Delobel-Ayoub; Catherine Arnaud; Mélanie White-Koning; Charlotte Casper; Véronique Pierrat; Micheline Garel; Antoine Burguet; Jean-Christophe Roze; Jacqueline Matis; Jean-Charles Picaud; Monique Kaminski; Béatrice Larroque
Journal:  Pediatrics       Date:  2009-06       Impact factor: 7.124

9.  Physicians in health care management: 3. Case Mix Groups and Resource Intensity Weights: an overview for physicians.

Authors:  G H Pink; H B Bolley
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

10.  Occurrence and severity of bronchopulmonary dysplasia and respiratory distress syndrome after a preterm birth.

Authors:  Jennifer S Landry; Dick Menzies
Journal:  Paediatr Child Health       Date:  2011-08       Impact factor: 2.253

View more
  11 in total

1.  Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.

Authors:  Rita M Ryan; Roberta L Keller; Brenda B Poindexter; Carl T D'Angio; Pamela A Shaw; Scarlett L Bellamy; Paul E Moore; Christopher McPherson; James M Greenberg
Journal:  J Pediatr       Date:  2019-03-08       Impact factor: 4.406

2.  Health Care and Societal Costs of Bronchopulmonary Dysplasia.

Authors:  Wannasiri Lapcharoensap; Henry C Lee; Amy Nyberg; Dmitry Dukhovny
Journal:  Neoreviews       Date:  2018-04

3.  Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age?

Authors:  A Lodha; K Ediger; Y Rabi; S Lodha; S Tang; A Bhandari; R Sauve; V Bhandari
Journal:  J Perinatol       Date:  2015-02-26       Impact factor: 2.521

Review 4.  Should we still use vitamin A to prevent bronchopulmonary dysplasia?

Authors:  X I Couroucli; J L Placencia; L A Cates; G K Suresh
Journal:  J Perinatol       Date:  2016-05-26       Impact factor: 2.521

5.  Medication utilization in children born preterm in the first two years of life.

Authors:  Jonathan C Levin; Andrew L Beam; Kathe P Fox; Kenneth D Mandl
Journal:  J Perinatol       Date:  2021-02-05       Impact factor: 2.521

6.  Drug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targets.

Authors:  Vineet Bhandari
Journal:  Front Pediatr       Date:  2014-07-25       Impact factor: 3.418

7.  Comparison of Follow-up Courses after Discharge from Neonatal Intensive Care Unit between Very Low Birth Weight Infants with and without Home Oxygen.

Authors:  Ji Sook Kim; Jae Won Shim; Jang Hoon Lee; Yun Sil Chang
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

8.  Sustained Reduction in Bloodstream Infections in Infants at a Large Tertiary Care Neonatal Intensive Care Unit.

Authors:  Sara Neill; Sarah Haithcock; P Brian Smith; Ronald Goldberg; Margarita Bidegain; David Tanaka; Charlene Carriker; Jessica E Ericson
Journal:  Adv Neonatal Care       Date:  2016-02       Impact factor: 1.874

9.  Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury.

Authors:  Camilia R Martin; Munir M Zaman; Calvin Gilkey; Maria V Salguero; Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke; Steven D Freedman
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

10.  The economic burden of prematurity in Canada.

Authors:  Karissa M Johnston; Katherine Gooch; Ellen Korol; Pamela Vo; Oghenowede Eyawo; Pamela Bradt; Adrian Levy
Journal:  BMC Pediatr       Date:  2014-04-05       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.